Ticker

Analyst Price Targets — ATEC

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
January 7, 2026 11:37 amBarclays$27.00$21.79TheFly Alphatec price target raised to $27 from $23 at Barclays
December 10, 2025 9:11 pmKeith HintonLoop Capital Markets$25.00$20.91StreetInsider Freedom Capital Markets Starts Alphatec Holdings (ATEC) at Buy
December 2, 2025 11:38 amMorgan Stanley$23.00$21.96TheFly Alphatec price target raised to $23 from $21 at Morgan Stanley
November 10, 2025 5:10 pmMorgan Stanley$21.00$20.44TheFly Alphatec price target raised to $21 from $16 at Morgan Stanley
November 3, 2025 11:25 amBarclays$23.00$18.99TheFly Alphatec price target raised to $23 from $22 at Barclays
October 31, 2025 1:02 pmMatthew O'BrienPiper Sandler$25.00$19.21StreetInsider Alphatec Holdings (ATEC) PT Raised; Piper Sandler: 'Strong Print and Positives Ahead'
October 31, 2025 12:40 pmLake Street$25.00$16.33TheFly Alphatec price target raised to $25 from $18 at Lake Street
October 31, 2025 10:21 amCanaccord Genuity$25.00$16.33TheFly Alphatec price target raised to $25 from $20 at Canaccord
October 31, 2025 10:06 amSean LeeH.C. Wainwright$24.00$16.33TheFly Alphatec price target raised to $24 from $20 at H.C. Wainwright
October 28, 2025 10:50 amStifel Nicolaus$20.00$16.78TheFly Alphatec resumed with a Buy at Stifel

Latest News for ATEC

Alphatec Holdings: Buy On Solid Results And Outlook

Over the course of 2025, Alphatec Holdings or "ATEC" has continued to outperform sales expectations and taken additional share in the $8 billion U.S. spinal disorder treatment market. In addition, the company has delivered vastly improved profitability and cash flow. While moderately lower growth expectations for 2026 appear to have impacted the stock price in recent weeks, I would consider the selloff a buying…

Seeking Alpha • Feb 27, 2026
ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2025, and business highlights. Fourth Quarter and Full-Year 2025 Financial Results Quarter Ended December 31, 2025 Year Ended December 31, 2025 Total revenue…

Business Wire • Feb 24, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for ATEC.

No House trades found for ATEC.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top